Celestra Inc. (KOSDAQ:352770)
South Korea · Delayed Price · Currency is KRW 5,247.38
0.00 (0.00%)
Last updated: Aug 4, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Bio | 7.08B | Log In | Log In | Log In | Log In | Upgrade |
Food and Food Service | 4.19B | Log In | Log In | Log In | Log In | Upgrade |
Investment | 935.84K | Log In | Log In | Log In | Log In | Upgrade |
Other | 143.50M | Log In | Log In | Log In | Log In | Upgrade |
Service - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Service - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - Others | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Service - GenoSolution | - | Log In | Log In | Log In | Log In | Upgrade |
Service - GenoSolution Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - AmoyDx ROS | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - AmoyDx ROS Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Service - AmoyDx ROS | - | Log In | Log In | Log In | Log In | Upgrade |
Service - AmoyDx ROS Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Service - BioComputer | - | Log In | Log In | Log In | Log In | Upgrade |
Service - BioComputer Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - BioServer | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - BioServer Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - CD-PRIME | - | Log In | Log In | Log In | Log In | Upgrade |
Manufactured - CD-PRIME Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Geno Cafe, Etc. | - | Log In | Log In | Log In | Log In | Upgrade |
Geno Cafe, Etc. Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Merchandised - COVID-19 | - | Log In | Log In | Log In | Log In | Upgrade |
Molecular Genetic Testing | - | Log In | Log In | Log In | Log In | Upgrade |
Molecular Genetic Testing Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
South Korea | 11.41B | Log In | Log In | Log In | Log In | Upgrade |
South Korea Growth | -50.58% | Log In | Log In | Log In | Log In | Upgrade |